Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma

Journal of Clinical Oncology

Volumn 31, Issue 20, 2013, Pages

  Peters, Solange ^a   Michielin, Olivier ^a   Zimmermann, Stefan ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CISPLATIN; GLUTAMIC ACID; PEMETREXED; VALINE; VEMURAFENIB; BRAF PROTEIN, HUMAN; INDOLE DERIVATIVE; SULFONAMIDE;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GENE MUTATION; HUMAN; IMAGE ANALYSIS; KERATOACANTHOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; PLEURODESIS; PRIORITY JOURNAL; SKIN DEFECT; TREATMENT OUTCOME; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; MUTATION; NEEDLE BIOPSY; PATHOLOGY; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TUMOR INVASION;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PNEUMONECTOMY; POLYMERASE CHAIN REACTION; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROTO-ONCOGENE PROTEINS B-RAF; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84883879311     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.6143     Document Type: Article

References (14)

1. Sequist LV, Heist RS, Shaw AT, et al: Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol 22:2616-2624, 2011
2. Kris MG, Johnson BE, Kwiatkowski DJ, et al: Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI's Lung Cancer Mutation Consortium (LCMC). J Clin Oncol 29:477s, 2011 (suppl; abstr CRA7506)
3. Marchetti A, Felicioni L, Malatesta S, et al: Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. J Clin Oncol 29:3574-3579, 2011
4. Paik PK, Arcila ME, Fara M, et al: Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. J Clin Oncol 29:2046-2051, 2011
5. Ji H, Wang Z, Perera SA, et al: Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models. Cancer Res 67:4933-4939, 2007
6. Sasaki H, Kawano O, Endo K, et al: Uncommon V599E BRAF mutations in Japanese patients with lung cancer. J Surg Res 133:203-206, 2006
7. Chapman PB, Hauschild A, Robert C, et al: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507-2516, 2011
8. Yang H, Higgins B, Kolinsky K, et al: RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models. Cancer Res 70:5518-5527, 2010
9. Pratilas CA, Hanrahan AJ, Halilovic E, et al: Genetic predictors of MEK dependence in non-small cell lung cancer. Cancer Res 68:9375-9383, 2008
10. Trejo CL, Juan J, Vicent S, et al: MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E. Cancer Res 72:3048-3059, 2012
11. Yang H, Higgins B, Kolinsky K, et al: Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. Cancer Res 72:779-789, 2012
12. Prahallad A, Sun C, Huang S, et al: Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature 483:100-103, 2012
13. Gautschi O, Pauli C, Strobel K, et al: A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib. J Thorac Oncol 7:e23-e24, 2012
14. Dummer R, Rinderknecht J, Goldinger SM: Ultraviolet A and photosensitivity during vemurafenib therapy. N Engl J Med 366:480-481, 2012